Dashboard
Financial statements
A

Company financials

Agilent Technologies

Health Care Life Sciences Tools & Services Santa Clara, California Last filing Dec 22, 2025 · FY2025
Revenue FY2025
$6.9B
3y CAGR +0.5% P18
Net income FY2025
$1.3B
Net margin +18.8% P76
Total assets FY2025
$12.7B
ROA +10.2% P73
Operating cash flow FY2025
$1.6B
FCF margin +16.6% P57
19 yrs · FY2007–FY2025 9 filed · 0 derived · 0 blank

Running CAGR since the earliest displayed year.

Balance Sheet

Assets, liabilities, and equity

26 accounts · 3 years
Total assets $12.7B
Total liabilities $6.0B
Shareholders equity $6.7B
Account 2025 2024 2023 Trend
Assets
Cash and Cash Equivalents +6.1% -16.4% —
Accounts Receivable +7.3% +2.6% —
Inventory -0.3% -5.7% —
Other Current Assets +3.4% +21.9% —
Total Current Assets +4.8% -5.4% —
Property,Plant and Equipment +26.2% +40.0% —
Goodwill +6.3% +13.1% —
Intangible Assets -3.2% +15.2% —
Long Term Investments -9.9% +6.7% —
Other Noncurrent Assets +22.3% +28.5% —
Total Assets +8.7% +10.1% —
Liabilities
Accounts Payable +16.8% +29.2% —
Accrued Liabilities +11.7% +12.6% —
Deferred Revenue +11.2% +7.7% —
Current Portion of Long Term Debt — — —
Total Current Liabilities +21.0% +18.2% —
Long Term Debt +5.6% +22.3% —
Other Noncurrent Liabilities +0.8% +22.1% —
Total Liabilities +10.3% +20.9% —
Equity
Preferred Stock — — —
Common Stock +0.0% +0.0% —
Additional Paid In Capital +1.7% +1.2% —
Retained Earnings +33.3% -4.1% —
Accumulated Other Comprehensive Income — — —
Total Stockholders Equity +7.4% +0.9% —
Total Liabilitiesand Equity +8.7% +10.1% —

Key Ratios

Margins, returns, liquidity, leverage, efficiency

Computed at import · 3 years
Ratio 2025 2024 2023
Profitability
Gross margin +52.4% +54.3% +50.7%
Operating margin +21.3% +22.9% +19.8%
Net margin +18.8% +19.8% +18.1%
FCF margin +16.6% +21.1% +21.6%
Growth
Revenue CAGR (3y) +0.5% +1.0% +8.6%
Returns
ROE +19.3% +21.9% +21.2%
ROA +10.2% +10.9% +11.5%
ROIC +16.2% +15.8% +17.9%
Liquidity
Current ratio 1.96x 2.09x 2.61x
Quick ratio 1.40x 1.40x 1.80x
Leverage
D/E 0.89x 1.01x 0.84x
Interest coverage 13.21x 15.50x 14.21x
Efficiency
Asset turnover 0.55x 0.55x 0.63x
Cash conversion cycle +128d +127d +135d

Valuation

Price against fundamentals

A $115 · 2026-04-02 · 212d old · FY2025
Market cap $32.9B
P/E 25.26x
P/S 4.74x
P/B 4.88x
EV $34.5B
EV/EBITDA —
FCF yield +3.5%
Dividend yield +0.9%

Notes

Your annotations

Not watched
Saving notes adds A to your watchlist.